Loading...
Loading...
All product recalls affecting Alaska.
Includes nationwide recalls (tagged “Nationwide”) and recalls with Alaska in the distribution area.
A half-threaded bolt was included in the LTE kits instead of the correct full-threaded bolt.
Chrysler (FCA US, LLC) is recalling certain 2024 Jeep Wrangler vehicles. The vehicles are equipped with incorrect tail lights that may be obstructed by the spare tire. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 108, "Lamps, Reflective Devices, and Associated Equipment."
General Motors, LLC (GM) is recalling certain 2023-2024 Cadillac LYRIQ all-wheel drive vehicles. The anti-lock brake system (ABS) may activate unexpectedly and release brake pressure in the vehicle's service brake system.
BMW of North America, LLC. (BMW) is recalling certain 540d xDrive vehicles that were previously repaired under recall number 22V-614. The exhaust gas recirculation (EGR) cooler may leak internally, causing coolant to mix with diesel engine soot, which could result in smoldering particles and a melting intake manifold.
Chrysler (FCA US, LLC) is recalling certain 2024 Jeep Grand Cherokee L vehicles. The child seat tether welds on the second-row seat back frame may be insufficient, which can reduce the seat's ability to properly restrain a child during a crash. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 225, "Child Restraint Anchorage Systems."
General Motors, LLC (GM) is recalling certain Buick Envision all-weather floor mats with part number 85647097, that may have been installed in certain 2024 Buick Envision vehicles. The accelerator pedal may become trapped under the floor mat, which can result in unintended acceleration.
Firm has developed a software correction (Revision D.00) outside the US to mitigate product problems that pose a risk of hemodynamic instability and failure of transmission of clinical data in Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pump devices.
Machines equipped with BPM3 Blood Pressure Modules (Blood pressure monitor TM-2917B with firmware version S005) will not record Blood Pressure measurements and does not alarm if the cuff tubing is kinked close to the cuff.
Superpotent Drug
Toyota Motor Engineering & Manufacturing (Toyota) is recalling certain 2025 Lexus UX300h vehicles. Certain wires in the engine room wire harness that supply power to the motor generator electronic control unit (MG ECU) may become fractured and separate, which can result in a loss of power.
Firm has developed a software correction (Revision D.00) outside the US to mitigate product problems that pose a risk of hemodynamic instability and failure of transmission of clinical data in Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pump devices.
Material with a quality issue was used in contact lens production, so contact lenses may not meet quality and/or performance standards for the entirety of their labeled shelf life, and wearing these lenses may lead to temporary issues such as irritation, redness, or blurred vision.
The National Institute of Standards and Technology (NIST) has identified in the National Vulnerability Database (NVD) that NexGen Healthcare Mirth Connect, prior to version 4.4.1, has a potential vulnerability allowing the deserialization of untrusted data (CVE-2023-43208). Mirth products may have been installed and configured with your ViewPoint / ViewPoint 6 system by GE HealthCare. This vulnerability could allow a malicious actor to access the system and potentially manipulate patient data.
Products expire prior to the expiration date printed on the product labeling
ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.
ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.
ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.
ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.
ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.
Some automated in vitro diagnostic modules and instruments manufactured or serviced between May 2022 and May 2024 were calibrated with internal equipment that may lead modules and instruments to report higher melting temperatures, which may lead to erroneous results including false positive Salmonella, Giardia lamblia, false positive/negative Norovirus, and false negative MRSA.